Uncommon Cents Investing’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.8M | Buy |
74,762
+1,580
| +2% | +$41.3K | 0.39% | 81 |
|
|
2026
Q1 | $2.05M | Buy |
73,182
+1,050
| +1% | +$28K | 0.48% | 72 |
|
|
2025
Q4 | $1.8M | Sell |
72,132
-700
| -1% | -$17.7K | 0.43% | 73 |
|
|
2025
Q3 | $1.86M | Buy |
72,832
+100
| +0.1% | +$2.47K | 0.46% | 71 |
|
|
2025
Q2 | $1.76M | Sell |
72,732
-2,655
| -4% | -$61.9K | 0.47% | 71 |
|
|
2025
Q1 | $1.91M | Buy |
75,387
+1,195
| +2% | +$31.3K | 0.56% | 59 |
|
|
2024
Q4 | $1.97M | Sell |
74,192
-1,811
| -2% | -$49.1K | 0.59% | 52 |
|
|
2024
Q3 | $2.2M | Sell |
76,003
-900
| -1% | -$26.3K | 0.62% | 51 |
|
|
2024
Q2 | $2.15M | Buy |
76,903
+500
| +0.7% | +$13.8K | 0.68% | 47 |
|
|
2024
Q1 | $2.12M | Buy |
76,403
+368
| +0.5% | +$10.2K | 0.65% | 50 |
|
|
2023
Q4 | $2.19M | Buy |
76,035
+1,373
| +2% | +$41.5K | 0.72% | 48 |
|
|
2023
Q3 | $2.48M | Sell |
74,662
-225
| -0.3% | -$7.96K | 0.91% | 34 |
|
|
2023
Q2 | $2.75M | Sell |
74,887
-915
| -1% | -$35.6K | 0.97% | 32 |
|
|
2023
Q1 | $3.09M | Buy |
75,802
+709
| +0.9% | +$30.6K | 1.13% | 24 |
|
|
2022
Q4 | $3.85M | Buy |
75,093
+357
| +0.5% | +$17.1K | 1.42% | 19 |
|
|
2022
Q3 | $3.27M | Sell |
74,736
-4,300
| -5% | -$209K | 1.37% | 18 |
|
|
2022
Q2 | $4.14M | Sell |
79,036
-60
| -0.1% | -$3.06K | 1.65% | 14 |
|
|
2022
Q1 | $4.09M | Sell |
79,096
-320
| -0.4% | -$16.6K | 1.48% | 17 |
|
|
2021
Q4 | $4.69M | Sell |
79,416
-336
| -0.4% | -$16.6K | 1.76% | 15 |
|
|
2021
Q3 | $3.43M | Sell |
79,752
-725
| -0.9% | -$32.1K | 1.39% | 20 |
|
|
2021
Q2 | $3.15M | Sell |
80,477
-480
| -0.6% | -$18.7K | 1.26% | 23 |
|
|
2021
Q1 | $2.93M | Sell |
80,957
-520
| -0.6% | -$18.5K | 1.26% | 22 |
|
|
2020
Q4 | $3M | Sell |
81,477
-3,140
| -4% | -$115K | 1.35% | 22 |
|
|
2020
Q3 | $2.95M | Buy |
84,617
+4,590
| +6% | +$161K | 1.5% | 18 |
|
|
2020
Q2 | $2.48M | Buy |
80,027
+10,508
| +15% | +$357K | 1.36% | 22 |
|
|
2020
Q1 | $2.15M | Buy |
69,519
+20,040
| +41% | +$683K | 1.34% | 23 |
|
|
2019
Q4 | $1.84M | Sell |
49,479
-31
| -0.1% | -$1.1K | 0.91% | 34 |
|
|
2019
Q3 | $1.69M | Buy |
49,510
+1,076
| +2% | +$39.1K | 1.08% | 33 |
|
|
2019
Q2 | $1.99M | Sell |
48,434
-580
| -1% | -$23K | 1.3% | 28 |
|
|
2019
Q1 | $1.98M | Buy |
49,014
+448
| +0.9% | +$17.9K | 1.29% | 30 |
|
|
2018
Q4 | $2.01M | Sell |
48,566
-3,431
| -7% | -$142K | 1.49% | 24 |
|
|
2018
Q3 | $2.17M | Sell |
51,997
-274
| -0.5% | -$10.5K | 1.36% | 26 |
|
|
2018
Q2 | $1.8M | Buy |
52,271
+4,232
| +9% | +$145K | 1.16% | 31 |
|
|
2018
Q1 | $1.62M | Buy |
48,039
+1,502
| +3% | +$51.6K | 1.14% | 31 |
|
|
2017
Q4 | $1.6M | Buy |
+46,537
| New | +$1.59M | 1.13% | 29 |
|
Other funds holding PFE
Uncommon Cents Investing's PFE Position: Q2 2026 in Review
Uncommon Cents Investing increased its Pfizer (PFE) stake by 2.2% in Q2 2026, buying an estimated $41.3K and bringing the position to 74,762 shares worth $1.8M. The position accounts for 0.39% of the portfolio, ranked #81.
Uncommon Cents Investing first reported a position in PFE in Q4 2017 and has held it in 35 quarters since. The position peaked at $4.69M in Q4 2021. 2,823 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Uncommon Cents Investing held 74,762 shares of Pfizer worth $1.8M as of Q2 2026.
- Uncommon Cents Investing bought 1,580 Pfizer shares in Q2 2026, an estimated $41.3K.
- Pfizer made up 0.39% of Uncommon Cents Investing's portfolio in Q2 2026, its #81 holding.
- Uncommon Cents Investing first reported a position in Pfizer in Q4 2017 and has held it in 35 quarters since.
- Uncommon Cents Investing's Pfizer position peaked at $4.69M in Q4 2021.
- 2,823 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Uncommon Cents Investing's 13F filing for Q2 2026, filed 20 Jul 2026.